Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Apellis Pharmaceuticals Inc’s stock clocked out at $26.33, down -2.12% from its previous closing price of $26.90. In other words, the price has decreased by -$2.12 from its previous closing price. On the day, 1.75 million shares were traded.
Ratios:
To gain a deeper understanding of APLS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.73 and its Current Ratio is at 4.36. In the meantime, Its Debt-to-Equity ratio is 1.98 whereas as Long-Term Debt/Eq ratio is at 1.96.
On November 21, 2024, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $31.
On October 25, 2024, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $25.RBC Capital Mkts initiated its Sector Perform rating on October 25, 2024, with a $25 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 11 ’25 when DeLong Mark Jeffrey sold 363 shares for $28.54 per share. The transaction valued at 10,360 led to the insider holds 83,945 shares of the business.
DeLong Mark Jeffrey bought 363 shares of APLS for $10,360 on Feb 11 ’25. On Jan 29 ’25, another insider, Watson David O., who serves as the General Counsel of the company, sold 695 shares for $29.52 each. As a result, the insider received 20,519 and left with 144,299 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.58 while its Price-to-Book (P/B) ratio in mrq is 13.55.
Stock Price History:
Over the past 52 weeks, APLS has reached a high of $71.90, while it has fallen to a 52-week low of $24.34. The 50-Day Moving Average of the stock is -13.48%, while the 200-Day Moving Average is calculated to be -22.82%.
Shares Statistics:
A total of 122.07M shares are outstanding, with a floating share count of 103.54M. Insiders hold about 16.76% of the company’s shares, while institutions hold 100.32% stake in the company.
